News Genetic testing could prevent three-quarters of avoidable side effects of some medicines, study suggests Researchers found that patients experiencing adverse drug reactions to treatments for psychiatric disorders and cardiovascular problems could benefit the most from personalised prescribing with pharmacogenomics.…Published: 1 April 2025
News Rapid on-site genetic sequencing could help curb antimicrobial-resistant outbreaks, says MHRA Researchers found that rapid on-site genetic sequencing detects bacterial infections within two days, which is “significantly faster“ than traditional methods.…Published: 7 March 2025
News Nine in ten people would accept a pharmacogenomics test, reveals survey The majority of respondents to a survey said they would be motivated to take a pharmacogenomics test to enhance drug effectiveness and reduce the risk of adverse drug reactions.…Published: 21 February 2025
News Pharmacogenomics trial expands across England Programme co-ordinators are aiming to recruit a further 1,450 people to the second phase of the PROGRESS trial, which is the first in the UK to introduce genetic testing before prescribing in primary care.…Published: 11 February 2025
News NICE approves gene-editing sickle cell therapy for NHS in England Exagamglogene autotemcel, also known as exa-cel, is now recommended for NHS use, reversing previous draft guidance.…Published: 4 February 2025
Opinion Top ten features of 2024 From dangerous new synthetic opioids to the use of artificial intelligence to transform drug discovery, our most popular features this year have covered a wide array of topics.…Published: 27 December 2024
News One-quarter of patients in pharmacogenomics trial have had prescriptions changed Around 25% of the 400 participants of the 'Progress programme' have been advised to change their prescription following genetic testing.…Published: 11 November 2024
News NHS Scotland scraps pharmacogenomic decision support service worth £66m The support service was designed to offer prescribers clinically actionable pharmacogenomics information when prescribing relevant drugs.…Published: 8 November 2024
News First gene-editing therapy recommended by NICE to treat people with beta thalassaemia NHS England said that around 460 patients aged 12 years and over could benefit from the treatment.…Published: 8 August 2024
Feature Closing the ethnicity gap in pharmacogenomics An overwhelming reliance on data from people with white, European ancestry threatens to make pharmacogenomics a poor tool for patients from other backgrounds.…Published: 7 August 2024
